Aurinia Pharmaceuticals Inc.
AUPH
$14.07
-$0.01-0.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.96% | 4.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.96% | 4.94% | |||
| Cost of Revenue | 376.82% | -41.54% | |||
| Gross Profit | -43.71% | 17.13% | |||
| SG&A Expenses | 11.74% | 0.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1,690.31% | -89.95% | |||
| Total Operating Expenses | -21.84% | -12.22% | |||
| Operating Income | 44.36% | 47.27% | |||
| Income Before Tax | 11.66% | 44.26% | |||
| Income Tax Expenses | -42,704.38% | -36.08% | |||
| Earnings from Continuing Operations | 568.11% | 46.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 568.11% | 46.66% | |||
| EBIT | 44.36% | 47.27% | |||
| EBITDA | 38.12% | 38.10% | |||
| EPS Basic | 567.34% | 50.09% | |||
| Normalized Basic EPS | 11.54% | 46.90% | |||
| EPS Diluted | 563.00% | 44.20% | |||
| Normalized Diluted EPS | 9.94% | 45.16% | |||
| Average Basic Shares Outstanding | 0.10% | -2.27% | |||
| Average Diluted Shares Outstanding | 1.58% | -1.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||